News & Alerts
-
Aug- 2023 -22 August
South African Court Backs Pharmacy-Initiated HIV Treatment
In a landmark decision this week, the Pretoria High Court has given the green light to the South African Pharmacy…
Read More » -
22 August
U.S. Patients Paying Up to 10 Times More for Ozempic, Rybelsus, Mounjaro, and Wegovy – KFF
In a startling revelation, a comparative analysis has shown that U.S. patients are paying up to 10 times more for…
Read More » -
21 August
FDA Halts Gilead’s Magrolimab Blood Cancer Trials
In a recent development, Gilead Sciences has faced a setback as the U.S. health regulator, the Food and Drug Administration…
Read More » -
21 August
FDA Greenlights New Eylea Formulation for Wet AMD, DME, and DR
The US Food and Drug Administration (FDA) has granted clearance for the new 8 mg formulation of Eylea (aflibercept), marking…
Read More » -
19 August
Regeneron’s Breakthrough Treatment, Veopoz, Granted FDA Approval for Rare Disease
In a significant development, Regeneron Pharmaceuticals, Inc. has announced the approval of Veopoz™ (pozelimab-bbfg) by the U.S. Food and Drug…
Read More » -
18 August
MSF Challenges GSK’s Contract Clauses for Access to Apretude
Médecins Sans Frontières (MSF), an international medical humanitarian organization, has been diligently working to secure access to ViiV Healthcare’s innovative…
Read More » -
18 August
Tukysa’s Trial Success Spurs Roche’s Kadcyla and Pfizer’s $43B Acquisition
Pfizer’s strategic move to acquire Seagen for $43 billion is primarily motivated by the Seattle biotech’s advantage in the field…
Read More » -
18 August
FDA Issues Warning to AstraZeneca for Misleading COPD Drug Advertising
The absence of any drug that demonstrates a significant improvement in all-cause mortality among patients with chronic obstructive pulmonary disease…
Read More » -
18 August
Tornado Fallout: 50% of Pfizer Hospital Injectables in Short Supply
As of August 16, 2023, approximately half of the injectable drug solutions produced by Pfizer Hospital US are experiencing significant…
Read More » -
18 August
Breaking Ground: FDA Approves Akeega for Aggressive Prostate Cancer Treatment
The U.S. Food & Drug Administration’s approval of Akeega marks a significant advancement in the treatment landscape for individuals with…
Read More »
